Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells -: art. no. 27

被引:70
作者
Mahyar-Roemer, M [1 ]
Köhler, H
Roemer, K
机构
[1] Univ Saarland, Sch Med, Inst Med Microbiol, Dept Virol, D-66421 Homburg, Germany
[2] Univ Saarland, Sch Med, Intern Med IV, D-66421 Homburg, Germany
关键词
D O I
10.1186/1471-2407-2-27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The natural plant polyphenol resveratrol present in some foods including grapes, wine, and peanuts, has been implicated in the inhibition, delay, and reversion of cellular events associated with heart diseases and tumorigenesis. Recent work has suggested that the cancer chemoprotective effect of the compound is primarily linked to its ability to induce cell division cycle arrest and apoptosis, the latter possibly through the activation of pro-apoptotic proteins such as Bax. Methods: The expression, subcellular localization, and importance of Bax for resveratrol-provoked apoptosis were assessed in human HCT116 colon carcinoma cells and derivatives with both bax alleles inactivated. Results: Low to moderate concentrations of resveratrol induced co-localization of cellular Bax protein with mitochondria, collapse of the mitochondrial membrane potential, activation of caspases 3 and 9, and finally, apoptosis. In the absence of Bax, membrane potential collapse was delayed, and apoptosis was reduced but not absent. Resveratrol inhibited the formation of colonies by both HCT116 and HCT116 bax -/- cells. Conclusion: Resveratrol at physiological doses can induce a Bax-mediated and a Bax-independent mitochondrial apoptosis. Both can limit the ability of the cells to form colonies.
引用
收藏
页数:9
相关论文
共 38 条
[1]  
Ahmad N, 2001, CLIN CANCER RES, V7, P1466
[2]   Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells [J].
Bernhard, D ;
Tinhofer, I ;
Tonko, M ;
Hübl, H ;
Ausserlechner, MJ ;
Greil, R ;
Kofler, R ;
Csordas, A .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (09) :834-842
[3]   Biological effects of resveratrol [J].
Bhat, KPL ;
Kosmeder, JW ;
Pezzuto, JM .
ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (06) :1041-1064
[4]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[5]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[6]  
Ciolino HP, 2001, ADV EXP MED BIOL, V492, P183
[7]  
Clément MV, 1998, BLOOD, V92, P996
[8]   Resveratrol arrests the cell division cycle at S/G2 phase transition [J].
Della Ragione, F ;
Cucciolla, V ;
Borriello, A ;
Della Pietra, V ;
Racioppi, L ;
Soldati, G ;
Manna, C ;
Galletti, P ;
Zappia, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (01) :53-58
[9]   Resveratrol, a remarkable inhibitor of ribonucleotide reductase [J].
Fontecave, M ;
Lepoivre, M ;
Elleingand, E ;
Gerez, C ;
Guittet, O .
FEBS LETTERS, 1998, 421 (03) :277-279
[10]   Resveratrol selectively inhibits leukemia cells:: a prospective agent for ex vivo bone marrow purging [J].
Gautam, SC ;
Xu, YX ;
Dumaguin, M ;
Janakiraman, N ;
Chapman, RA .
BONE MARROW TRANSPLANTATION, 2000, 25 (06) :639-645